Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma. (Q39982741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

title

Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Jianjun Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

Zhao Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

Yan Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

Duane D Miller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

Wei Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

3183-3187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

Synthesis and antiproliferative activity of thiazolidine analogs for melanoma.

7 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Diagnosis and treatment of cutaneous melanoma: state of the art 2006.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Melanoma biology and new targeted therapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Chemotherapy for metastatic melanoma: time for a change?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Chemotherapy for metastatic melanoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Synthesis and identification of small molecules that potently induce apoptosis in melanoma cells through G1 cell cycle arrest

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Treatment of metastatic malignant melanoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Prognostic factors in 1,521 melanoma patients with distant metastases

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Systemic treatments for advanced cutaneous melanoma.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-alpha) in metastatic melanoma

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494854

Desazadesmethyldesferrithiocin analogues as orally effective iron chelators

2 December 2018

1 reference

12 December 2020

Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole

1 reference

12 December 2020

Synthesis and antiinflammatory activity of 2,2'-diaminobiphenyl derivatives

1 reference

12 December 2020

Optically active derivatives of imidazolines. .alpha.-Adrenergic blocking properties

1 reference

12 December 2020

10.1016/J.BMCL.2008.04.073

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

release_cw437mauu5ej3inzjh3rup6gsq

7 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cw437mauu5ej3inzjh3rup6gsq

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18477505 AND SRC:MED&resulttype=core&format=json

7 January 2020

PubMed publication ID

18477505

1 reference